Retinoid Receptors

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 525-530

  Davidovici, Batya B ^a   Tüzün, Yalçin ^b   Wolf, Ronni ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BEXAROTENE; INTERFERON; RETINOID; RETINOID RECEPTOR; TAZAROTENE; UNCLASSIFIED DRUG;

ACNE; BONE PAIN; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; GENE TARGETING; HEADACHE; HUMAN; HYPERTRIGLYCERIDEMIA; ICHTHYOSIS; PHOTOAGING; PRIORITY JOURNAL; RETINOIC ACID SYNDROME; REVIEW; SIDE EFFECT; SKIN CANCER; SKIN TOXICITY; THROMBOSIS; UTERINE CERVIX CANCER;

ANIMALS; DERMATOLOGIC AGENTS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, RETINOIC ACID; RETINOIDS; SKIN PHYSIOLOGY;

EID: 34648839872     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.016     Document Type: Review

References (46)

1. Sporn M.B., Dunlop N.M., Newton D.L., et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35 6 (1976) 1332-1338
2. Karrer P., Morf R., and Schopp K. [The knowledge of vitamin A from fish oil]. Helv Chim Acta 14 (1931) 1036-1041 [in German]
3. Kligman A.M., Fulton Jr. J.E., and Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol 99 (1969) 469-476
4. Petkovich M., Brand N.J., Krust A., et al. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330 (1987) 444-450
5. Giguére V., Ong E.S., Segui P., et al. Identification of a receptor for the morphogen retinoic acid. Nature 330 (1987) 624-629
6. Nguyen E.H., and Wolverton S.E. Systemic retinoids. In: Wolverton S.E., and Wilkin J.K. (Eds). Systemic drugs for skin diseases (2000), WB Saunders, Philadelphia 269-310
7. Schwartz E., Mezick J.A., Gendimenico C.J., et al. In vivo prevention of corticosteroid-induced skin atrophy by tretinoin in the hairless mouse is accompanied by modulation of collagen, glycosaminoglycans, and fibronectin. J Invest Dermatol 102 (1994) 241-246
8. Saiag P., Pavlovic M., Clerici T., et al. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA. AIDS 12 16 (1998) 2169-2176
9. Nagpal S., Cai J., Zheng T., et al. Retinoid antagonism of NF-IL6: insight into the mechanism of antiproliferative effects of retinoids in Kaposi's sarcoma. Mol Cell Biol 17 7 (1997) 4159-4168
10. Corbeil J., Rapaport E., Richman D.D., et al. Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells. J Clin Invest 93 5 (1994) 1981-1986
11. Duvic M., Friedman-Kien A.F., Looney D.J., et al. Topical treatment of cutaneous lesions of AIDS-related Kaposi's sarcoma using 9-cis-retinoic acid (alitretinoin) gel: results of phase 1 and 2 trials. Arch Dermatol 136 (2000) 1461-1469
12. Zhang C., and Duvic M. Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma. Dermatol Ther 16 4 (2003) 322-330
13. Chomienne C., Fenaux P., and Degos L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J 10 9 (1996) 1025-1030
14. Nagpal S., and Chandraratna R.A. Recent developments in receptor-selective retinoids. Curr Pharm Des 6 9 (2000) 919-931
15. Wang Z.Y., Chen Z., Huang W., et al. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA). Blood Cells 19 3 (1993) 633-641
16. Yu V.C., Delsert C., Andersen B., et al. RXR b: a co-regulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response element. Cell 67 (1991) 1251-1266
17. Levin A.A., Sturzenbecker L.J., Kazmer S., et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR a. Nature 355 (1992) 359-361
18. Elder J.T., Astrom A., Pettersson U., et al. Differential regulation of retinoic acid receptors and binding proteins in human skin. J Invest Dermatol 98 (1992) 673-679
19. Fisher G.J., Talwar H.S., Xiao J.H., et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 269 (1994) 20629-20635
20. Xiao J.H., Durand B., and Chambon P. Endogenous retinoic acid receptor -retinoid X receptor heterodimers are the major functional forms regulating retinoid-responsive elements in adult human keratinocytes. J Biol Chem 270 (1995) 3001-3011
21. Armstrong R.B., Ashenfelter K.O., Eckhoff C., et al. General and reproductive toxicology of retinoids. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The retinoids: biology, chemistry, and medicine (1994), Raven Press, New York 545-572
22. Sanquer S., and Gilchrest B.A. Characterization of human cellular retinoic acid-binding proteins -I and -II: ligand binding affinities and distribution in skin. Arch Biochem Biophys 311 (1994) 86-94
23. Aström A., Tavakkol A., Pettersson U., et al. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. J Biol Chem 266 (1991) 17662-17666
24. Fisher G.J., Reddy A.P., Datta S.C., et al. All-trans retinoic acid induces cellular retinol-binding protein in vivo. J Invest Dermatol 105 (1995) 80-86
25. Rosenthal D.S., Griffiths C.E., Yuspa S.H., et al. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol 98 (1992) 343-350
26. Rosenthal D.S., Roop D.R., Huff C.A., et al. Changes in photo-aged human skin following topical application of all-trans retinoic acid. J Invest Dermatol 95 (1990) 510-515
27. Saatcioglu F., Claret F.X., and Karin M. Negative transcriptional regulation by nuclear receptors. Semin Cancer Biol 5 (1994) 347-359
28. Pfahl M. Nuclear receptor/AP-1 interaction. Endocr Rev 14 (1993) 651-658
29. Chen J.Y., Penco S., Ostrowski J., et al. RAR-specific agonist/antagonists which dissociate transactivation and AP-1 transrepression inhibit anchorage-independent cell proliferation. EMBO J 14 (1995) 1187-1197
30. Dawson M.I., Jong L., and Hobbs P.D. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J Med Chem 38 (1995) 3368-3383
31. Lehmann J.M., Jong L., Fanjul A., et al. Retinoids selective for retinoid X receptor response pathways. Science 258 (1992) 1944-1946
32. Tavakkol A., Griffiths C.E., Keane K.M., et al. Cellular localization of mRNA for cellular retinoic acid-binding protein II and nuclear retinoic acid receptor-gamma 1 in retinoic acid-treated human skin. J Invest Dermatol 99 (1992) 146-150
33. Chen S., Ostrowski J., Whiting C., et al. Retinoic acid receptor gamma mediates topical retinoid efficacy and irritation in animal models. J Invest Dermatol 104 (1995) 779-783
34. Gendimenico G.J., Stim T.B., Corbo M., et al. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by all-trans-retinoic acid, a RAR agonist but not by SRi 11237, a RXR-selective agonist. J Invest Dermatol 102 5 (1994) 676-680
35. Scheinman R.I., Gualberto A., Jewell C.M., et al. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15 (1995) 943-953
36. Caldenhoven E., Liden J., Wissink S., et al. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9 (1995) 401-412
37. Fanjul A., Dawson M.I., Hobbs P.D., et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372 (1994) 107-111
38. Hirose T., Apfel R., Pfahl M., et al. The orphan receptor TAK1 acts as a repressor of RAR-, RXR- and T3R-mediated signaling pathways. Biochem Biophys Res Commun 211 (1995) 83-91
39. Cooney A., Tsai S., O'Malley B., et al. Chicken ovalbumin upstream promoter transcription factor (COUP-IF) dimers bind to different GGTCA response elements, allowing COUP-IF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors. Mol Cell Biol 12 (1992) 4153-4163
40. Bernard B.A. Adapalene, a new chemical entity with retinoid activity. Skin Pharmacol 6 Suppl 1 (1993) 61-69
41. Griffiths C.E., Elder J.T., Bernard B.A., et al. Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol 101 (1993) 325-328
42. Elder J.T., Kaplan A., Cromie M.A., et al. Retinoid induction of CRABP II mRNA in human dermal fibroblasts: use as a retinoid bioassay. J Invest Dermatol 106 (1996) 517-521
43. Nagpal S., Athanikar J., and Chandraratna R.A. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J Biol Chem 270 (1995) 923-927
44. Trent J.T., Romanelli P., and Kerdel F.A. Topical targretin and intralesional interferon alfa for cutaneous lymphoma of the scalp. Arch Dermatol 138 11 (2002) 1421-1423
45. Zackheim H.S., Kashani-Sabet M., and Main S. Treatment of mycosis fungoides with topical corticosteroids: a second look. J Clin Dermatol 1 (1998) 15-20
46. Duvic M., Olsen E.A., Omura G.A., et al. A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 44 6 (2001) 940-947